患者对过敏性鼻炎治疗的期望:一种混合方法研究
Ana Noreña-Peña1,2, Fernando Mugarza Borque2,3, Jorge Mestre-Ferrandiz3
1Department of Nursing, University of Alicante, Alicante, Spain.
Patient preference and adherence
|November 3, 2025
概括
患者对过敏性鼻炎 (AR) 治疗的看法表明,满意度取决于不仅仅是疗效. 解决患者对个性化护理,更好的沟通和教育的需求对于改善AR管理中的坚持和生活质量至关重要.
科学领域:
- 过敏和免疫学的过敏和免疫学.
- 患者为中心的护理
- 健康研究成果研究结果
背景情况:
- 过敏性鼻炎 (AR) 显著影响患者的生活质量.
- 了解患者的期望对于有效的AR治疗和坚持治疗至关重要.
研究的目的:
- 探索中度至重度AR患者对其治疗的主观经验.
- 在AR管理中识别患者的期望,需求和坚持因素.
主要方法:
- 混合方法研究结合了定量调查 (75名患者) 和定性焦点组 (7名患者).
- 通过西班牙过敏和呼吸系统疾病患者协会联合会 (FENAER) 进行的横截面观察设计.
主要成果:
- 大多数患者 (73.3%) 感到满意,但由于对疗效的担忧,许多人考虑改变治疗.
- 报告的坚持率很高 (54.7%),但成本是26.7%的障碍.
- 患者希望获得更多的教育,并强调需要个性化治疗,简单的管理和更好的提供者沟通.
结论:
- 以患者为中心的方法对于优化AR管理至关重要.
- 治疗的满意度和坚持程度受到管理的方便性,副作用和沟通的影响,而不仅仅是疗效.
- 让患者参与治疗决策可以提高治疗结果和生活质量.
更多相关视频
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Drugs Used in Upper Respiratory Disorders: Overview
616
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
616
Drugs Used in Lower Respiratory Disorders: Overview
1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K
Allergic Reactions
32.0K
Overview
32.0K
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K


